Post by
besttobe on Jul 28, 2021 9:37am
DME stocks in disarray - out of favor
Aphia - convicted of fraud for filing false claims by OIG.
Adapth - Former CEO was accused of fraud and now company is being investaged for posibble fraud, plus just received a nasty short report for over-estimating organic growth.
VMD- Flat net earnings and declinig growth, plus just received a scathing OIG report that is still in limbo.
General industry issues -
1. Rollups out of favor.
2. Disruptive supplychain issues, due to Phillips recall of over 2 million pieces of respritory equipment in the US.
3.Lack of workers in the tight US labor market and rising employee costs to attract them,
4.Rising equipment cost with stagnant reimbursement rates.
5.Insurance companies attacks in reimbursement rates for high margin vents.
6.Lastly, rotation out of poorly preforming health care stocks in general.
The only trade I see from low liquitity unprofitable rollup Quipt, is a one time pop off the low, if they announce a" move the needle" aquisition. I doubt we see that anytime soon. Maybe later in the year, given their history of how slow they are to pull the trigger, between aquisitions. Other than that, I see no longterm upside for this stock. IMO
GLTA
GLTA
Comment by
Carlito3311 on Jul 28, 2021 11:08am
This post has been removed in accordance with Community Policy
Comment by
gibbonsj on Jul 28, 2021 11:37am
This is laughable. Grow a pair and take advantage of the situation. The co. is doing very well, the benefit of the last tuckins will come. Glad you knuckle heads aren't running the company. Remember the q3 extraordinary tailwinds we were told to expect? Management has not lied about anything.
Comment by
besttobe on Jul 28, 2021 12:25pm
I would not be buying now. It is going to be a falling knife for awhile yet. IMO. Q3 will disappoint as Q2 did. Q3 will show...More cash burn, low organic growth, more losses and missed targets. IMO This thing will be low for awhile andis going lower. ...IMO. Time to buy will be after Q3 report or before if the stock goes under $6.50. . IMO. Patience... GLTA